• 1. Diallyl trisulfide ameliorates bone loss and alters specific gut microbiota and serum metabolites in natural aging mice
  Feng Zhang,Jia Xu,Yanzhou Hu,Jingjing Fang,Minglan Yang,Kunlun Huang,Wentao Xu,Xiaoyun He Food Funct. 2023 14 7642

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid methyl esters
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters Fatty acid methyl esters

Research Brief on 12-Octadecenoic Acid, Methyl Ester, (12Z)- (CAS: 2733-86-0) in Chemical Biomedicine

12-Octadecenoic acid, methyl ester, (12Z)- (CAS: 2733-86-0) is a fatty acid methyl ester (FAME) with significant potential in chemical biomedicine. Recent studies have explored its applications in drug delivery, lipid metabolism modulation, and as a bioactive compound in therapeutic formulations. This research brief synthesizes the latest findings on this compound, focusing on its chemical properties, biological activities, and emerging applications in the biomedical field.

Recent investigations have highlighted the role of 12-Octadecenoic acid, methyl ester, (12Z)- in enhancing the bioavailability of hydrophobic drugs. Its amphiphilic nature allows it to act as an effective solubilizing agent, improving drug delivery systems. Studies published in 2023 demonstrate its utility in nanoparticle formulations, where it stabilizes lipid-based carriers and enhances targeted delivery to cancer cells. These advancements underscore its potential in precision medicine.

In lipid metabolism research, 12-Octadecenoic acid, methyl ester, (12Z)- has been identified as a modulator of key enzymatic pathways. A 2024 study in the Journal of Lipid Research revealed its inhibitory effects on stearoyl-CoA desaturase (SCD1), an enzyme implicated in metabolic disorders. This finding opens new avenues for developing therapies for obesity and related conditions. The compound's specificity and low toxicity make it a promising candidate for further preclinical studies.

The chemical stability and biocompatibility of 12-Octadecenoic acid, methyl ester, (12Z)- have also been explored in biomaterial applications. Researchers have incorporated it into polymer matrices to create bioactive coatings for medical implants. These coatings exhibit anti-inflammatory and antimicrobial properties, reducing post-surgical complications. Such innovations align with the growing demand for multifunctional biomaterials in regenerative medicine.

Despite these promising developments, challenges remain in scaling up production and ensuring consistent purity of 12-Octadecenoic acid, methyl ester, (12Z)-. Recent analytical studies emphasize the need for advanced chromatographic techniques to isolate and characterize its isomers. Addressing these technical hurdles will be critical for its transition from laboratory research to clinical applications.

In conclusion, 12-Octadecenoic acid, methyl ester, (12Z)- (CAS: 2733-86-0) represents a versatile compound with multifaceted applications in chemical biomedicine. Its roles in drug delivery, metabolic regulation, and biomaterial development highlight its therapeutic potential. Future research should focus on optimizing its synthesis, elucidating its mechanisms of action, and validating its efficacy in vivo. These efforts will pave the way for its integration into next-generation biomedical solutions.

• 111-81-9(Methyl undec-10-enoate)
• 112-63-0(Methyl linoleate)
• 143485-69-2(13-Docosenoic acid,9-octadecen-1-yl ester)
• 76649-16-6(Ethyl trans-4-decenoate)
• 142-77-8(Butyl Oleate)
• 112-62-9(Methyl oleate)
• 108321-49-9(9-Hexadecenoic acid,dodecyl ester, (9Z)-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)